Drug that restricts blood supply to prostate tumors delays disease progression
Tuesday, June 8, 2010 - 18:00
in Health & Medicine
A blood vessel-blocking drug called tasquinimod slowed the rate of disease progression in a clinical trial of 200 prostate cancer patients, according to experts at Johns Hopkins, Roswell Park Cancer Institute and Duke University.